SCN1A gene therapy(Pharma Gateway)

N/A

Report date: 2024/07/17 11:05:24

Base Information

Drug NameSCN1A gene therapy(Pharma Gateway)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSodium channel protein type I alpha subunit modulators
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharma Gateway AB
China Registration ClassN/A

Develop Information

Active CompaniesPharma Gateway AB
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A